EUVIMEDEUVIMED entdecken
Open Access

Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study.

Elham Kashafi Jahromi, Solmaz Nasseri Maleki, Michael R Hamblin, Fatemeh Ramezani, Nahid Aboutaleb

Archives of Academic Emergency Medicine · 01.01.2026 · 14 (1) · e29-e29

DOI: 10.22037/aaem.v14i1.2941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Academic Emergency Medicine, erschienen am 01.01.2026. Verfasst von Elham Kashafi Jahromi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nanocarrier-mediated delivery represents a promising strategy for enhancing the therapeutic efficacy of pharmacological agents. This study investigated whether encapsulating the endogenous peptide apelin-13 in niosomes (Nano-Apelin13) could improve its protective effects against ischemic stroke injury in rats.

Methods

Transient focal cerebral ischemia was induced by 60-minute middle cerebral artery occlusion (MCAO) followed by 24-hour reperfusion. Sixty rats were randomly allocated into five experimental groups: Sham, CI/R (ischemia/reperfusion), CI/R + empty niosomes, CI/R + free Apelin13, and CI/R + Nano-Apelin13. Free Apelin13 and Nano-Apelin13 (40 µg/kg) were administered intravenously 1 hour after reperfusion onset. After 24 hours, cerebral infarction size, neurological deficit scores, brain water content, and neuronal damage were evaluated. Protein expression levels of TLR4, MyD88, NF-κB, TNF-α, and IL-1β were analyzed by western blotting.

Results

Both free Apelin13 and Nano-Apelin13 significantly reduced cerebral infarct volume, improved neurological scores, decreased neuronal loss, and downregulated MyD88 and NF-κB expression. However, Nano-Apelin13 demonstrated superior efficacy, normalizing several parameters to sham-operated levels. Notably, Nano-Apelin13 significantly suppressed TLR4 expression and attenuated cerebral edema and pro-inflammatory cytokine production, effects that were either significantly enhanced or absent in the free Apelin13-treated group.

Conclusion

Delivery of Apelin13 in niosomes could be a good option to reduce CI/R damage by inhibiting the activity of TLR4/MyD88/NF-kB axis compared to free Apelin13.

Schlagwörter

Stichwörter der Autor:innen

ApelinApelin-13 peptide; Drug Delivery SystemsBrain IschemiaMyeloid Differentiation Factor 88Signal TransductionToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
  • Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa.

Zitieren

APA

Kashafi Jahromi, E., Nasseri Maleki, S., Hamblin, M. R., Ramezani, F., & Aboutaleb, N. (2026). Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study. Archives of Academic Emergency Medicine, 14(1), e29-e29. https://doi.org/10.22037/aaem.v14i1.2941

Vancouver

Kashafi Jahromi E, Nasseri Maleki S, Hamblin MR, Ramezani F, Aboutaleb N. Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study. Archives of Academic Emergency Medicine. 2026;14(1):e29-e29. doi:10.22037/aaem.v14i1.2941

BibTeX
@article{KashafiJahromi2026,
  author = {Kashafi Jahromi, Elham and Nasseri Maleki, Solmaz and Hamblin, Michael R and Ramezani, Fatemeh and Aboutaleb, Nahid},
  title = {Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study},
  journal = {Archives of Academic Emergency Medicine},
  year = {2026},
  volume = {14},
  number = {1},
  pages = {e29--e29},
  doi = {10.22037/aaem.v14i1.2941}
}
Kostenlos starten →